Regenxbio Inc. · NASDAQ:RGNX
Pakola Steve sold 2,161 Regenxbio Inc. shares (Form 4)
Traded Jul 2, 2026 · Filed Jul 6, 2026
On Jul 2, 2026, Pakola Steve (Chief Medical Officer) sold 2,161 Regenxbio Inc. shares at US$13.64 for US$29,476 under a trading plan, leaving 213,009 shares. Filed Jul 6, 2026 (Form 4).
- Sold
- 2,161 shares
- Price
- US$13.64
- Value
- US$29,476
- Holding after
- 213,009 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 2, 2026 | Common Stock | Option exercise | 2,161 | US$7.86 | 215,170 | Direct |
| Jul 2, 2026 | Common Stock | Sale | 2,161 | US$13.64 | 213,009 | Direct |
Source
Related
- Regenxbio Inc.
- Pakola Steve
- Regenxbio Inc. shareholders
- Form 4 · Pakola Steve · Aug 4, 2026
- Form 4 · Pakola Steve · Jul 1, 2026
- Form 4 · Pakola Steve · May 13, 2026
- Schedule 13G · JPMorgan Chase & Co · Oct 13, 2026
- Form 4 · Malzahn Craig · Sep 3, 2026
- Form 4 · Chan Mitchell · Sep 3, 2026
- Form 4 · Ciongoli Gregory Austin · Aug 27, 2026
- Form 4 · Christmas Patrick J. · Aug 4, 2026